KR960004887B1 - 경구 활성 항바이러스성 화합물 - Google Patents

경구 활성 항바이러스성 화합물 Download PDF

Info

Publication number
KR960004887B1
KR960004887B1 KR1019930703932A KR930703932A KR960004887B1 KR 960004887 B1 KR960004887 B1 KR 960004887B1 KR 1019930703932 A KR1019930703932 A KR 1019930703932A KR 930703932 A KR930703932 A KR 930703932A KR 960004887 B1 KR960004887 B1 KR 960004887B1
Authority
KR
South Korea
Prior art keywords
compound
carbon
alkyl
compounds
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930703932A
Other languages
English (en)
Korean (ko)
Inventor
엠. 기리야발라반 비이요르
케이. 강굴리 아쉬트
더블유. 버세이스 리챠드
케이. 삭시나 아닐
에이. 핀토 패트릭
Original Assignee
쉐링 코포레이션
에릭 에스. 딕커
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 코포레이션, 에릭 에스. 딕커 filed Critical 쉐링 코포레이션
Application granted granted Critical
Publication of KR960004887B1 publication Critical patent/KR960004887B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
KR1019930703932A 1991-06-19 1992-06-17 경구 활성 항바이러스성 화합물 Expired - Fee Related KR960004887B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71745191A 1991-06-19 1991-06-19
US07/717,451 1991-06-19
PCT/US1992/004961 WO1992022520A1 (en) 1991-06-19 1992-06-17 Orally active antiviral compounds

Publications (1)

Publication Number Publication Date
KR960004887B1 true KR960004887B1 (ko) 1996-04-16

Family

ID=24882086

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930703932A Expired - Fee Related KR960004887B1 (ko) 1991-06-19 1992-06-17 경구 활성 항바이러스성 화합물

Country Status (23)

Country Link
US (4) US5559133A (enExample)
EP (2) EP0519702A1 (enExample)
JP (1) JP2625258B2 (enExample)
KR (1) KR960004887B1 (enExample)
AT (1) ATE182874T1 (enExample)
AU (1) AU674657B2 (enExample)
CA (1) CA2111854C (enExample)
CZ (1) CZ279793A3 (enExample)
DE (1) DE69229733T2 (enExample)
ES (1) ES2134808T3 (enExample)
FI (1) FI935690A0 (enExample)
IE (1) IE921971A1 (enExample)
IL (1) IL102241A0 (enExample)
MX (1) MX9203068A (enExample)
MY (1) MY107993A (enExample)
NZ (1) NZ243180A (enExample)
OA (1) OA09828A (enExample)
PL (1) PL169699B1 (enExample)
SK (1) SK144293A3 (enExample)
TW (1) TW260658B (enExample)
WO (1) WO1992022520A1 (enExample)
YU (1) YU63392A (enExample)
ZA (1) ZA924445B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0519702A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds
AU691490B2 (en) * 1993-02-26 1998-05-21 Schering Corporation Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans
AU6783698A (en) * 1997-04-10 1998-10-30 Pharmacia & Upjohn Company Polyaromatic antiviral compositions
AU6462500A (en) * 1999-07-29 2001-02-19 Patrick T. Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418571A1 (de) * 1973-04-18 1974-11-14 Ciba Geigy Ag Phenyl-aralkyl-aether, diphenyle und benzophenone, verfahren zu ihrer herstellung und ihre verwendung
JPS509785A (enExample) * 1973-05-31 1975-01-31
JPS5922697B2 (ja) * 1976-01-13 1984-05-28 エーザイ株式会社 ビス−（メタ−アミジノフエノキシ）−化合物
JPS5651423A (en) * 1979-09-13 1981-05-09 Wellcome Found Antiviral agent
EP0099933B1 (en) * 1982-01-29 1986-04-02 Toray Industries, Inc. Process for preparing alpha,omega-bis(2-chlorophenoxy)-alkane-4,4'-dicarboxylic acid or its lower alkyl ester
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
JPH0621083B2 (ja) * 1986-12-22 1994-03-23 株式会社三光開発科学研究所 ジ（アリ−ルオキシ）アルカンの製造方法
US4891449A (en) * 1988-06-30 1990-01-02 Great Lakes Chemical Corporation Halogenated unsymmetrical higher alkyl phenoxy alkanes
AU6062590A (en) * 1989-07-07 1991-02-06 Schering Corporation Pharmaceutically active compounds
EP0519702A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds

Also Published As

Publication number Publication date
CA2111854C (en) 2001-01-09
DE69229733D1 (de) 1999-09-09
US5350772A (en) 1994-09-27
CZ279793A3 (en) 1994-05-18
TW260658B (enExample) 1995-10-21
PL169699B1 (en) 1996-08-30
EP0519702A1 (en) 1992-12-23
YU63392A (sh) 1994-11-15
ATE182874T1 (de) 1999-08-15
OA09828A (en) 1994-04-15
WO1992022520A1 (en) 1992-12-23
US5618849A (en) 1997-04-08
ZA924445B (en) 1993-02-24
EP0590026B1 (en) 1999-08-04
US5449782A (en) 1995-09-12
FI935690A7 (fi) 1993-12-17
AU2221392A (en) 1993-01-12
DE69229733T2 (de) 1999-12-02
JPH06503839A (ja) 1994-04-28
FI935690A0 (fi) 1993-12-17
JP2625258B2 (ja) 1997-07-02
AU674657B2 (en) 1997-01-09
MY107993A (en) 1996-07-15
EP0590026A1 (en) 1994-04-06
NZ243180A (en) 1995-08-28
CA2111854A1 (en) 1992-12-23
US5559133A (en) 1996-09-24
IL102241A0 (en) 1993-01-14
MX9203068A (es) 1993-07-01
ES2134808T3 (es) 1999-10-16
IE921971A1 (en) 1992-12-30
SK144293A3 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
US5366997A (en) Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
HUT70511A (en) New leukotriene-b4 antagonists, process for preparing the same and pharmaceutical comns. contg. them
FR2567510A1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
KR960004887B1 (ko) 경구 활성 항바이러스성 화합물
EP1001944B1 (fr) Derives de pyrazine, leur preparation et les medicaments les contenant
EP0274064B1 (en) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene pgi2 derivatives
US4585589A (en) Water-soluble alkanoyloxy and alkoxycarbonyloxy rifampicin derivatives, process for its preparation, intermediates, and its pharmaceutical composition as antibacterials
AU745905B2 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
US4812472A (en) Isoxazole compounds and pharmaceutical compositions containing them for treatment and prophylaxis of retroviruses diseases
EP0550568A1 (en) Anti-atherosclerotic aryl compounds
CA1092120A (fr) Derives de l'hydroxy-4 thiazolidine thione-2, leur preparation et les compositions qui les contiennent
CH679859A5 (enExample)
EP0718307A2 (fr) Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique
JPH0723367B2 (ja) オキサビシクロヘプタン誘導体
SI9400221A (en) Orally active antipicornaviral compounds
DK165920B (da) Selektive biologisk aktive 7-oxo-prostacyclinderivater og fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DE4436578A1 (de) Neue alpha,alpha,alpha',alpha'-Tetrachlordicarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
NZ270131A (en) Orally active antiviral aromatic ether compounds
HRP920365A2 (en) Bis(oxy) compounds and process for their preparation
JP3228533B2 (ja) アゾキシ基含有化合物
CH679858A5 (enExample)
JPS61277650A (ja) ７−オキソ−ｐｇｉ２エフエドリン塩類似体，その製造方法および医薬組成物
JPS62226953A (ja) ベンゾキノニルフエニル酪酸アミド誘導体
HU191216B (en) Process for the synthesis of stable 4,4-dioxo-4-thia-prostacycline derivatives
JPH0348665A (ja) （ｒ）―１，２―ビスジオキソピペラジンプロパン誘導体

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19990417

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19990417

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000